Type of publication:
Journal article

Author(s):
Ellenbogen J.R., Waqar M., Denning D.W., Cooke R.P.D., *Skinner D.W., Lesser T., Javadpour M.

Citation:
Journal of Clinical Neuroscience, October 2014, vol./is. 21/10(1825-1827), 0967-5868;1532-2653 (01 Oct 2014)

Abstract:
Cerebral aspergillosis is a rare manifestation of invasive aspergillosis that usually affects immunocompromised patients. There are few treatment options for recurrent disease and experiences with immunocompetent patients are lacking. We report the clinical course of an immunocompetent patient with recurrent cerebral aspergillosis, following initial treatment with burr hole aspiration and voriconazole, who showed remarkable response to posaconazole. The patient remains clinically well with no evidence of recurrence on MRI 7 years following diagnosis. To our knowledge this is the first reported experience with posaconazole in an immunocompetent patient with cerebral aspergillosis.

Link to more details or full-text: